Switch from Sliding Scale to Basal-Plus Insulin Immediately
Even though discharge is only 2 weeks away, you should transition this patient from sliding scale insulin alone to a basal-plus regimen now, as sliding scale insulin is condemned by current guidelines and associated with worse glycemic control and increased complications 1.
Why Sliding Scale Alone Is Inadequate
The glucose range of 125-232 mg/dL demonstrates exactly why sliding scale fails—it only treats hyperglycemia after it occurs rather than preventing it. Current guidelines explicitly discourage sliding scale insulin alone in patients with diabetes, as it is associated with:
- Clinically significant hyperglycemia in many patients 1
- Worse glycemic control compared to basal-bolus or basal-plus approaches 1
- Increased complications including postoperative wound infections, pneumonia, bacteremia, and acute renal/respiratory failure 1
- Guidelines have advised against this approach for nearly 20 years 2
Recommended Approach: Basal-Plus Regimen
For this patient with mild-to-moderate hyperglycemia (peak 232 mg/dL), implement a basal-plus regimen consisting of:
Basal Insulin Dosing
- Start with 0.1-0.25 units/kg/day of long-acting basal insulin (glargine or detemir) given once daily 1
- This lower dose range is appropriate because the patient has relatively mild hyperglycemia (peak <250 mg/dL)
- If the patient is elderly (>65 years), has renal impairment, or has poor oral intake, use the lower end (0.1 units/kg/day) 1
Correction Insulin
- Continue rapid-acting insulin for correction doses before meals or every 6 hours if NPO 1
- This addresses glucose elevations while the basal insulin provides background coverage
Why This Matters for a 2-Week Stay
The "temporary" nature of the hospitalization is not a valid reason to continue suboptimal therapy. Two weeks of poor glycemic control increases risks of:
- Hospital-acquired infections
- Delayed wound healing
- Respiratory complications
- Acute kidney injury
- These complications can extend hospitalization beyond the planned 2 weeks 1
Common Pitfall to Avoid
Do not assume that "temporary" means sliding scale is acceptable. The evidence shows sliding scale alone should only be used in patients without diabetes who have mild stress hyperglycemia, or in patients with good baseline control on oral agents alone who cannot maintain glucose <180 mg/dL 1. For patients with established diabetes requiring insulin, basal-plus is safer and more effective.
Hypoglycemia Risk Management
While basal-bolus regimens carry 4-6 times higher hypoglycemia risk than sliding scale 1, the basal-plus approach (using lower basal doses with correction insulin) mitigates this concern while still providing superior glycemic control. The incidence of severe hypoglycemia remains low in controlled settings 1.
Discharge Planning
At discharge in 2 weeks: